SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 50 filers reported holding SQZ BIOTECHNOLOGIES CO in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,680 | -77.2% | 15,500 | -8.2% | 0.00% | – |
Q3 2022 | $38,000 | -81.1% | 16,891 | -73.3% | 0.00% | – |
Q2 2022 | $201,000 | +44.6% | 63,241 | +118.0% | 0.00% | – |
Q1 2022 | $139,000 | +31.1% | 29,013 | +145.0% | 0.00% | – |
Q4 2021 | $106,000 | -35.4% | 11,844 | +3.9% | 0.00% | – |
Q3 2021 | $164,000 | – | 11,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NanoDimension, Inc. | 1,445,221 | $6,952,000 | 15.25% |
683 Capital Management, LLC | 2,098,815 | $10,096,000 | 0.54% |
Artal Group S.A. | 1,606,309 | $7,726,000 | 0.32% |
Sandy Cove Advisors, LLC | 51,707 | $249,000 | 0.21% |
MAVERICK CAPITAL LTD | 1,056,786 | $5,083,000 | 0.09% |
ACT CAPITAL MANAGEMENT, LLC | 16,000 | $77,000 | 0.08% |
AMERICAN INTERNATIONAL GROUP, INC. | 2,528,477 | $12,162,000 | 0.07% |
Temasek Holdings (Private) Ltd | 2,758,169 | $13,266,793 | 0.06% |
Alphabet Inc. | 103,929 | $500,000 | 0.02% |
Baldrige Asset Management LLC | 5,000 | $24,000 | 0.01% |